Gilead's second HIV pre exposure prophylaxis (PrEP) medication has been approved for marketing
JESUS60
发表于 2024-1-8 20:29:13
1281
0
0
On January 8th, according to the official WeChat account of Geely Technology, DaKeWei& Reg; Enqutabine Propenofovir Tablets (II), Enqutabine 200mg/Propenofovir 25mg, F/TAF) have been approved by the National Medical Products Administration (NMPA) for pre exposure prophylaxis (PrEP) for adults and adolescents at least 35kg in weight at risk of human immunodeficiency virus type 1 (HIV-1) infection, to reduce the risk of HIV-1 infection due to high-risk sexual behavior. Previously, Gilead Entratabine Propenofovir Tablets had been approved in China for use in combination with other antiretroviral drugs in the treatment of HIV-1 infections in adults and adolescents (aged 12 years and above and weighing at least 35kg).
Pre exposure prevention refers to the use of specific antiviral drugs by individuals who have not yet been infected with HIV before engaging in behaviors that are susceptible to HIV infection, in order to prevent HIV infection. It is an important biomedical measure for HIV prevention. In August 2020, Gilead Scientific Enqutabine Tenofovir tablets were approved, becoming the first drug in China approved for pre exposure prevention of HIV in uninfected populations.
At present, sexual transmission has become the main route of HIV transmission in China. More than 95% of newly diagnosed HIV infected individuals in our country are infected through sexual means, and unsafe sexual behavior is the main cause of HIV sexual transmission. Unsafe sexual behaviors with a high risk of HIV infection include unprotected male same-sex sex, non fixed sexual partners, and paid sex.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- The Class 1 new drug introduced by Anjin with over 1 billion US dollars has been approved for clinical use
- JD Allianz Equity Transfer Approved: Allianz Insurance Group to Transfer 53.33% Equity of the Company to Allianz China Holdings
- Sanofi: Targeted therapy drug for chronic obstructive pulmonary disease (COPD), Dabitou, approved in China
- Intel Technology is expected to complete $8.5 billion in financing by the end of the year; A total of 109 domestic online games were approved in September
- Johnson&Johnson's drug Zebaike has been approved in China
- Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
- Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
- The third quarter reports of Geely and Jike have been released! What are the reasons for the integration of internal resources or the acquisition of controlling stakes?
- Baiao Zhihui and Gilead Science signed an asset purchase agreement
- Baiao Zhihui and Gilead Science signed an asset purchase agreement
-
知名做空机构香橼研究(Citron Research)周四(11月21日)在社交媒体平台X上发布消息称,该公司已决定做空“比特币大户”微策略(Microstrategy)这家公司,并认为该公司已经将自己变身成为一家比特币投资基金 ...
- caffycat
- 11 小时前
- 支持
- 反对
- 回复
- 收藏
-
每经AI快讯,11月20日,文远知行宣布旗下自动驾驶环卫车S6与无人扫路机S1分别在新加坡滨海湾海岸大道与滨海艺术中心正式投入运营。据介绍,这是新加坡首个商业化运营的自动驾驶环卫项目。 ...
- star8699
- 前天 19:48
- 支持
- 反对
- 回复
- 收藏
-
上证报中国证券网讯(记者王子霖)11月20日,斗鱼发布2024年第三季度未经审计的财务报告。本季度斗鱼依托丰富的游戏内容生态,充分发挥主播资源和新业务潜力,持续为用户提供高质量的直播内容及游戏服务,进一步 ...
- goodfriendboy
- 前天 20:09
- 支持
- 反对
- 回复
- 收藏
-
人民网北京11月22日电 (记者栗翘楚、任妍)2024广州车展,在新能源汽车占据“半壁江山”的同时,正加速向智能网联新能源汽车全面过渡,随着“端到端”成为新宠,智能驾驶解决方案成为本届广州车展各大车企竞 ...
- 3233340
- 5 小时前
- 支持
- 反对
- 回复
- 收藏